PE50697A1 - Compuesto antibacteriano de carbapenem y procedimiento de preparacion - Google Patents

Compuesto antibacteriano de carbapenem y procedimiento de preparacion

Info

Publication number
PE50697A1
PE50697A1 PE1996000312A PE00031296A PE50697A1 PE 50697 A1 PE50697 A1 PE 50697A1 PE 1996000312 A PE1996000312 A PE 1996000312A PE 00031296 A PE00031296 A PE 00031296A PE 50697 A1 PE50697 A1 PE 50697A1
Authority
PE
Peru
Prior art keywords
methyl
preparation procedure
carbapenem
antibacterial compound
dioxolen
Prior art date
Application number
PE1996000312A
Other languages
English (en)
Spanish (es)
Inventor
George Burton
Stephen Frederick Moss
Alfred John Eglington
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508957.9A external-priority patent/GB9508957D0/en
Priority claimed from GBGB9508955.3A external-priority patent/GB9508955D0/en
Priority claimed from GBGB9508956.1A external-priority patent/GB9508956D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PE50697A1 publication Critical patent/PE50697A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PE1996000312A 1995-05-03 1996-05-03 Compuesto antibacteriano de carbapenem y procedimiento de preparacion PE50697A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9508957.9A GB9508957D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508955.3A GB9508955D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508956.1A GB9508956D0 (en) 1995-05-03 1995-05-03 Novel compounds

Publications (1)

Publication Number Publication Date
PE50697A1 true PE50697A1 (es) 1997-12-18

Family

ID=27267696

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000312A PE50697A1 (es) 1995-05-03 1996-05-03 Compuesto antibacteriano de carbapenem y procedimiento de preparacion

Country Status (22)

Country Link
EP (1) EP0823910A1 (fr)
JP (1) JPH11504910A (fr)
KR (1) KR19990008355A (fr)
CN (1) CN1185783A (fr)
AR (1) AR005416A1 (fr)
AU (1) AU5813996A (fr)
BG (1) BG102014A (fr)
BR (1) BR9608313A (fr)
CA (1) CA2217990A1 (fr)
CZ (1) CZ347597A3 (fr)
EA (1) EA199700293A1 (fr)
HU (1) HUP9801066A3 (fr)
IL (1) IL118092A0 (fr)
MA (1) MA23853A1 (fr)
MX (1) MX9708421A (fr)
NO (1) NO974994L (fr)
OA (1) OA10632A (fr)
PE (1) PE50697A1 (fr)
PL (1) PL323141A1 (fr)
SK (1) SK146497A3 (fr)
TR (1) TR199701286T1 (fr)
WO (1) WO1996034868A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902659A1 (fr) 2006-06-23 2007-12-28 Pierre Fabre Medicament Sa Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires
WO2013157583A1 (fr) * 2012-04-18 2013-10-24 大日本住友製薬株式会社 Nouveau composé de carbapénème

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
CA1212105A (fr) * 1980-04-30 1986-09-30 Shoji Ikeda Esters d'ampiciline, et leur production
AU7467194A (en) * 1993-08-18 1995-03-14 Sankyo Company Limited Crystalline carbapenem derivatives
CA2175054C (fr) * 1993-10-29 2005-07-12 Steven Coulton Derives de 2-(pyrazol-3-yle)carbapenem

Also Published As

Publication number Publication date
BG102014A (en) 1998-11-30
CN1185783A (zh) 1998-06-24
EA199700293A1 (ru) 1998-06-25
WO1996034868A1 (fr) 1996-11-07
AR005416A1 (es) 1999-06-23
KR19990008355A (ko) 1999-01-25
CA2217990A1 (fr) 1996-11-07
HUP9801066A3 (en) 1999-01-28
CZ347597A3 (cs) 1998-08-12
IL118092A0 (en) 1996-09-12
MX9708421A (es) 1998-02-28
BR9608313A (pt) 1999-01-26
PL323141A1 (en) 1998-03-16
NO974994D0 (no) 1997-10-30
JPH11504910A (ja) 1999-05-11
EP0823910A1 (fr) 1998-02-18
MA23853A1 (fr) 1996-12-31
NO974994L (no) 1997-10-30
HUP9801066A2 (hu) 1998-08-28
OA10632A (en) 2002-09-16
TR199701286T1 (xx) 1998-02-21
SK146497A3 (en) 1998-05-06
AU5813996A (en) 1996-11-21

Similar Documents

Publication Publication Date Title
EE03194B1 (et) Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod
LU91216I2 (en) Noxafil-posaconazole
DK0840732T3 (da) Substituerede benzolactamforbindelser som substans P-antagonister
ES2183473T3 (es) Derivados de acido piridonacarboxilico como agentes antibacterianos.
FR2446289A1 (fr) Compose de 2-penem, procede de preparation et composition pharmaceutique obtenue
PT876388E (pt) Derivados de eritromicina triciclica
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
CU22953A3 (es) Procedimiento para la preparación de ácidos 8-metoxiquinoloncarboxílicos
MX9708696A (es) Cefalosporinas antibacterianas.
WO2001091796A8 (fr) Methodes, composes et compositions permettant de traiter la goutte
PE50697A1 (es) Compuesto antibacteriano de carbapenem y procedimiento de preparacion
AU571206B2 (en) 6-hydroxyalkyl-penem derivatives
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
CA1272726C (fr) 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl) azetidines
FI860426A0 (fi) Primycinkomponenter samt foerfarande foer avskiljning av antibiotkomplex.
MA26735A1 (fr) Formes cristallines nouvelles d'un antibiotique macrolide, procede pour leur preparation et compositions pharmaceutiques les contenant
BR0013751A (pt) Processo para produção de derivados de ácido naftiridina-3-carboxìlico
TR199902820T2 (xx) Multisiklik eritromisin t�revleri.
ES530508A0 (es) Un metodo de preparar 2'-desoxioxanosina
CO4600751A1 (es) Alcohol de guayaba
ES2172699T3 (es) Procedimiento para la preparacion de prostaglandina e1.
ES2114477B1 (es) Nuevas cafalosporinas.
TR28369A (tr) Ikili cam elyafinin üretimine yönelik cam kompozisyonlari.
IT1298541B1 (it) Processo per la preparazione di s-alchilcisteine
BG102535A (en) Dihydrate of (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate of 4,10 beta-diacetoxy-2 alpha-benzoyloxy-5 beta, 20-epoxy-1-hydroxy-9-oxo-19-nor-cyclopropa[g]tax-11-ene 13-alpha -yl and method for its preparaton

Legal Events

Date Code Title Description
FD Application declared void or lapsed